News

The drug demonstrated safety profile and positive results when investigated in open-label, randomized, multicenter, controlled Phase 3 studies comparing two dose regimens of Nulojix with another immunosuppressant cyclosporine.

The company also expects to open offices in other counties of APAC like South Korea, Taiwan, Malaysia and Indonesia. ClinTec CEO president and founder Rabinder Buttar said since

The patents cover the formulations, compositions and processing methodology of the liquid pain reliever drug. Aquaprin is an acid free aspirin and is designed to instantly dissolve in

Earlier this year, Boehringer Ingelheim and Lilly collaborated in the field of diabetes that centers on four pipeline compounds representing several of the largest treatment classes. Tradjenta, which

As per the two-year agreement, the companies will use technology developed at the Massachusetts Eye and Ear Infirmary in the Eaton-Peabody Laboratory by investigator and Audion co-founder Albert

The tie up allows Nycomed to become the sole marketing authorization holder in all the licensed territories. Bonviva is a bisphosphonate used in the treatment of osteoporosis in

The company’s technology suite consists of Enlighten, iMedNet EDC and EMPOWER. Enlighten is a clinical trial management solution contains easy-to-use electronic data capture (EDC) capabilities, data management tools

NeurogesX has recruited around 183 patients for this trial. The Phase 2 clinical study design included two stages. The first stage was intended to establish the shortest tolerable

The new patent entitled, ‘KAPPA-OPIATE AGONISTS FOR THE TREATMENT OF DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME,’ covers the usage of asimadoline in treating diarrhea predominant irritable bowel syndrome (D-IBS). The